Watchlist Price Alert

Phoenix Biotech Acquisiti... (PBAXU)

NASDAQ: PBAXU · Real-Time Price · USD

10.37

-0.01 (-0.10%)

At close: Feb 07, 2024, 2:37 PM

Phoenix Biotech Acquisition Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021
Period Ending	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021
Revenue	254.83K	254.83K	254.83K	254.83K	n/a	n/a	n/a	n/a	n/a
Cost of Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Gross Profit	254.83K	254.83K	254.83K	254.83K	n/a	n/a	n/a	n/a	n/a
Operating Income	-1.33M	-1.61M	-178.88K	-378B	-378B	-378B	-378B	-332.03K	n/a
Interest Income	380.58K	579.53K	466.14K	357.58K	357.58K	37.11K	n/a	n/a	n/a
Pretax Income	-1.91M	-1.45M	-172.29K	-68.58K	-677.01K	-821.98K	-710.41K	-332.42K	n/a
Net Income	-2.41M	-1.99M	-890.8K	378B	378B	378B	378B	-315.55K	n/a
Selling & General & Admin	3.89M	4.25M	3.05M	2.84M	1.72M	933.06K	606.48K	251.71K	n/a
Research & Development	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Expenses	-83.85K	-34.95K	37.75K	64.05K	150K	100K	50K	n/a	n/a
Operating Expenses	3.85M	4.26M	3.09M	2.91M	1.95M	1.11M	736.81K	332.03K	n/a
Interest Expense	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	3.85M	4.26M	3.09M	2.91M	1.95M	1.11M	736.81K	332.03K	n/a
Income Tax Expense	500.55K	535.26K	718.51K	-378B	-378B	-378B	-378B	-16.87K	n/a
Shares Outstanding (Basic)	6.33M	6.77M	6.77M	22.98M	22.98M	22.98M	22.98M	n/a	22.98M
Shares Outstanding (Diluted)	6.33M	6.77M	6.77M	22.98M	22.98M	22.98M	22.98M	n/a	22.98M
EPS (Basic)	-0.33	-0.27	-0.08	16.45K	16.45K	16.45K	16.45K	n/a	n/a
EPS (Diluted)	-0.33	-0.27	-0.08	16.45K	16.45K	16.45K	16.45K	n/a	n/a
EBITDA	-5.77M	-6.84M	-5.9M	-5.74M	-2.87M	-1.37M	-763.59K	-332.03K	n/a
EBIT	378K	378K	378K	-378B	-378B	-378B	-378B	n/a	n/a
Depreciation & Amortization	-4.28M	-5.07M	-5.68M	377.99B	377.99B	378B	378B	125.39K	54K